LPA and familial hyperaldosteronism: Furthermore, the distribution of Lp(a) levels appears indistinguishable from that in control subjects (see especially Figs. 1 and 2), indicating that “elevated” Lp(a) levels are just as likely to be seen in patients with FH as in normolipidemic control individuals without FH.